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a b s t r a c t
Deep vein thrombosis (DVT) is a major health problem in pregnancy and postpartum period.
Catheter-directed thrombolysis (CDT) is safe and effective in the management of symptom-
atic DVT. Value of CDT in postpartum DVT is not fully evaluated. We describe ﬁve patients
presenting with acute iliofemoral DVT in their early postpartum period who were treated
with mechanical thromboaspiration and CDT. The CDT was done using streptokinase
infusion and unfractionated heparin. Percutaneous angioplasty was done in patients with
symptomatic residual lesion following thrombolysis. Patients were discharged with oral
anticoagulant and compression stockings. This approach was successful in all ﬁve cases.
Percutaneous endovascular therapy using CDT, mechanical thromboaspiration, and balloon
angioplasty is safe and effective in iliofemoral DVT in postpartum period.
# 2015 Cardiological Society of India. Published by Elsevier B.V. All rights reserved.
Available online at www.sciencedirect.com
ScienceDirect
journal homepage: www.elsevier.com/locate/ihj1. Introduction
Worldwide, deep vein thrombosis (DVT) and venous throm-
boembolism (VTE) are major health problems with high
mortality and morbidity in pregnancy and postpartum period.1
The high incidence of DVT and risk of VTE during pregnancy
and postpartum period occurs due to hypercoagulable state.2
Catheter-directed thrombolysis (CDT) is a safe and effective
method by lysing the thrombus and restoring the patency of
the veins in proximal DVT.3 It reduces the incidence of post-
thrombophlebitic syndrome (PTS) and improves the quality of
life.3 Pregnancy and the postpartum period are considered as
relative contraindications for thrombolysis.4 However, CDT of* Corresponding author.
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by restoring early patency of veins.4 We share our experience
of safety and efﬁcacy of CDT in treatment of proximal DVT in
postpartum period.
2. Case report
Eight patients were admitted to our hospital with proximal
DVT in postpartum period in the last year. Among them, ﬁve
patients were treated with CDT along with mechanical
thromboaspiration, and the remaining three patients were
treated with low molecular weight heparin and oral anticoag-
ulant. The mean age of these patients was 22 years. The mean B.V. All rights reserved.
Table 1 – Demographic, clinical features and treatment outcome of treated patients.
Variable Case 1 Case 2 Case 3 Case 4 Case 5
Age 24 years 22 years 29 years 20 years 23 years
Risk factor Postpartum,
left leg polio
Postpartum Abortion, left
ankle fracture
Postpartum Postpartum
Onset after
delivery
8 days 7 days 10 days 7 days 10 days
Presentation Left leg swelling,
renal angle
tenderness
Right leg swelling Bilateral leg
swelling
Right leg swelling Right leg swelling
Duplex
venography
Left iliofemoral,
IVC and RVT
Rt. Iliofemoral +
IVC thrombosis
B/L iliofemoral +
IVC thrombosis
Rt. Iliofemoral
thrombosis
Rt. Iliofemoral
thrombosis
Treatment CDT CDT CDT CDT CDT
Duration of CDT 120 h 140 h 144 h 110 h 120 h
Result of CDT Partial lysis Complete lysis Complete lysis Complete lysis Complete lysis
Angioplasty PTA done PTA done + IVC ﬁlter PTA done + IVC ﬁlter PTA done PTA done
Adverse events
of therapy
Nil Minor bleeding,
anemia,
IVC ﬁlter not retrieved
Minor bleeding,
Thrombocytopenia,
anemia
Minor bleeding,
Thrombocytopenia,
anemia
Minor bleeding,
anemia
Symptoms at
discharge
Pain and edema
decreased
Pain and edema
decreased
Pain and edema
decreased
Pain and edema
decreased
Pain and edema
decreased
Follow-up at
6 months
Mild PTS No PTS No PTS No PTS No PTS
Fig. 1 – IVC venogram showing the proximal level of DVT
with involvement of right common iliac vein and extending
into IVC.
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Three patients had right lower limb DVT, one patient had left
lower limb DVT, and another patient had bilateral lower limb
DVT. Four patients had normal vaginal delivery, whereas one
patient had second trimester abortion following trauma. All of
these patients were primigravida and there was no family
history of thrombotic disorder. Two patients had history of
using oral contraceptive pills in the past. BMI was low or in
normal range in these patients. All patients had iliofemoral
DVT, three patients had extension into inferior vena cava
(IVC), and one had additional renal vein thrombosis (RVT).
After ruling out risk factors and contraindication for systemic
thrombolysis, CDT was started locally through ipsilateral
popliteal vein (PV). The mean duration of CDT was 128 (16) h.
Three patients had complete resolution of clot and another
case had partial resolution. One case had received infusion of
Urokinase after giving 2 days of Streptokinase infusion, as
there was no signiﬁcant improvement after giving streptoki-
nase. In the patient with RVT with mild renal dysfunction,
renal function was improved after CDT. Mechanical throm-
boaspiration was done by using a 7F multipurpose catheter
(Cordis, Miami, Florida) and 50 cc syringe for aspiration. IVC
ﬁlter was used in two patients prior to CDT and mechanical
thromboaspiration. Percutaneous transluminal angioplasty
(PTA) was done by using peripheral angioplasty balloon in
patients for residual lesion in iliac veins. Three patients had
minor bleeding from the local site; two patients required blood
transfusion and two patients had thrombocytopenia which
recovered gradually. In one patient, IVC ﬁlter could not be
retrieved (Table 1). All patients improved symptomatically. At
6 months of follow-up, one patient had mild PTS. Three
patients did not give consent for CDT. Table 1 describes the
demographic, clinical features, and treatment outcome of
these patients.
Intervention: CDT was done using PV cannulation. PV
sheath insertion (8F sheath) was performed under ultrasound
guidance. One patient had bilateral PV sheath insertion.Peripheral venogram was done through PV sheath to assess
the extent of thrombus. The thrombotic lesion was crossed
with a 0.0350 angled Terumo guide wire with 6F multipurpose
(MP) guiding catheter (Cordis, Miami, Florida) and IVC
venogram was performed to assess the proximal level of
thrombus (Fig. 1). Multiple holes were made in the distal 5–
10 cm of the MP catheter and it was placed in the proximal part
of the DVT. Injection streptokinase 100,000 units/h infusion
was given of which two-third dose (70,000 units/h) was
through catheter and one-third dose (30000 units/h) through
sheath. Injection of unfractionated heparin (UFH) 800–1000
Fig. 2 – Peripheral venous angioplasty of right common iliac
vein.
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thromboplastin time (APTT) was monitored to maintain APTT
between 60 and 90 s. Mechanical thromboaspiration was done
using 8F MP catheter attached with a 50 ml syringe in those
patients who did not show response to thrombolysis.
Venogram was repeated after 24 h and infusion was continued
till there was a satisfactory result or any sign of adverse events
present. Percutaneous transluminal angioplasty (PTA) wasFig. 3 – Venogram demonstrating >90% resolution of venous
clot and IVC filter was also implanted in this patient.performed if there was signiﬁcant residual stenosis in the
affected vein (Fig. 2). The treatment was considered successful
if there was resolution of thrombus, good antegrade ﬂow, and
less than 30% residual luminal area narrowing (Fig. 3), along
with complete or partial resolution of symptoms of DVT like
lower extremity pain and edema. Following thrombolytic
therapy, patients were discharged with graduated compres-
sion stockings, and anticoagulated with oral nicoumalone for 6
months a year (or lifelong in case of prothrombotic disorder)
according to the American College of Chest Physician (ACCP)
guidelines.4 The International Normalized Ratio (INR) was
maintained between 2 and 3. During follow-up of 6 months,
only one patient had mild PTS and the remaining were
completely free of symptoms.
3. Discussion
Pregnancy and postpartum period are associated with an
overall 5–10 fold increased risk of VTE.5 The absolute risk is
highest during and shortly after delivery. Furthermore, during
the puerperium, the risk of developing DVT is signiﬁcantly
higher than antepartum.6,7 In majority of the cases, DVT arises
in left lower extremity due to a relative stenosis of the left
common iliac vein where it lies between the lumbar vertebral
body and the right common iliac artery.5 But in our cases,
involvement of right leg was more than left leg without any
obvious reason. The treatment of VTE has advanced signiﬁ-
cantly in recent years, but major challenges remain. Despite
use of standard therapies, VTE continues to a signiﬁcant risk
factor for death or major disability.8 Signiﬁcant portion of
patients develop post-thrombophlebitic syndrome despite
adequate anticoagulation therapy.9 In venous thromboembol-
ic disease, CDT with or without assisted mechanical throm-
bolysis is becoming the standard of medical care in the
treatment of acute DVT.10 Anticoagulation therapy is ineffec-
tive at removing thrombus of the deep venous system, and
when extensive, DVT carries a high risk of developing PTE and
PTS.11 To avoid PTS, aggressive therapy to remove venous
thrombus/venous obstruction must be undertaken before
irreversible valvular damage occurs.12 Nevertheless, during
the last decade, advances in minimally invasive technologies
have spurred a renaissance in the aggressive treatment of DVT
using percutaneous techniques.11 Endovascular management
using percutaneous mechanical thrombectomy alone or in
combination with pharmacological thrombolytic agents has
recently received much attention in the literature as a safe and
effective means for the treatment of acute DVT.12 Fibrinolysis
is relatively contraindicated during pregnancy and postpar-
tum period due to high incidence of bleeding risk.4 A few
studies which showed that CDT can be safely used in
postpartum period.4,7 Successful CDT in our patients also
conﬁrmed the same. But there are some differences between
previous studies and treatment pattern in our patients. We
have used streptokinase through popliteal vein approach of
same side, whereas the previous study used alteplase as
ﬁbrinolytic agent. In a previous study, CDT with alteplase was
used for a maximum period of 4 days,4 whereas, another
study12 had used streptokinase for CDT through PV, similar to
what we have done in our cases. We have used streptokinase
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mechanical thromboaspiration. The complications of CDT
seen our cases were anemia (due to mechanical thromboas-
piration), thrombocytopenia (heparin induced), minor bleed-
ing, and nonretrieval of IVC ﬁlter. These were more than the
previous study may be due to longer duration of CDT. But these
adverse events were mild, nonlife threatening with the beneﬁt
of complete lysis. Thrombophilia screening was not performed
in every case.
4. Conclusion
Our prospective case analysis demonstrated that percutane-
ous endovascular therapy consisting of CDT with PTA and/or
stenting in selected cases may be safe and effective in
iliofemoral DVT during post-partum period; however, larger
studies are required to conﬁrm the results.
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